Actoplus Met XR
* PIOGLITAZONE/METFORMIN
Actoplus Met Drug Information
Actoplus Met is used in the management of Type 2 Diabetes Mellitus. Patients must bear in mind that this oral formulation is used to be used in combination with nutritional management and regular exercise for effective management of diabetes. Usually, patients who don’t respond appropriately to generic Metformin are put on Actoplus Met regimen. As with all oral anti-hyperglycemic drugs, this medication must be only be consumed after the primary cause for diabetes has been investigated. This formulation brings about its action by a mechanism that causes increased sensitivity of insulin and also by decreasing the endogenous production of glucose by the liver.
Actoplus Met Dosage Information
Actoplus Met is a combination of Pioglitazone/ Metformin. As with most anti-diabetic regimens, the treatment with this drug is individualized and dosage tends to differ from patient to patient. However, the usual recommended doses are 15/ 850 mg to 30/ 1000 mg. North Meds sells discount Actoplus Met at doses of 15/ 850 mg. Our online pharmacy is a safe, easy and trusted place to buy cheap Actoplus Met.
Side Effects and Precautions for Actoplus Met
This Pioglitazone/ Metformin combination is most commonly associated with side effects such as upper respiratory tract infections, edema, headaches and diarrhoea. A few cases of the detrimental effect of the drug on existing diabetic macular edema and a decrease in acuity of vision have also been reported. The development of metabolic disturbances such as lactic acidosis, especially when there is hypoxemia, is a possibility with the use of this drug combination. It is very important that patients with diabetic ketoacidosis not use this drug. Patients with kidney disorders can also encounter serious complications after administration of this drug; such patients should therefore consult a doctor before they buy Actoplus Met and consume it.
* All trademarks and registered trademarks are the property of their respective owners.
